Home Authors Posts by Bernard Vaughan

Bernard Vaughan

Target: Zest Anchors Inc. Sponsor: The Jordan Company LP Seller: Zest Anchors Inc. The Jordan Company LP has bought Zest Anchors Inc., an Escondido, Calif.-based company that makes attachments used to secure dentures and other dental implants, according to Paul Zuest, the president of the company. Jordan Company purchased a majority stake while Zuest and […]
Firm: Resource Capital Funds Fund: Resource Capital Fund V LP Target: $800 million – $1 billion Placement Agent: None Executives at Resource Capital Funds, a Denver-based firm that invests in mining companies, expect to close their fifth fund at $1 billion in the first quarter of 2010, a source familiar with the firm’s plans told […]
Firm: EnCap Investments LP Fund: EnCap Investments Energy Capital Fund VIII Target: TBD Placement Agent: TBD EnCap Investments LP is plotting its eighth fund and may need a placement agent to help it tap international investors. David Miller, a co-founder of the Houston based firm, told Buyouts that EnCap will start raising the fund late […]
Firm: The Riverside Company Fund: Riverside Capital Appreciation Fund V LP Target: $900 million Placement Agent: None The Riverside Company has surged past its target for its latest North American buyout fund, which it expects to close May 31, according to sources close to the effort. The lower mid-market buyout specialist has raised $950 million, […]
Firm: Lovell Minnick Partners Fund: Lovell Minnick Equity Partners III LP Target: $350 million Amount Raised: $365 million Placement Agent: Credit Suisse Lovell Minnick Partners, a buyout shop investing in the financial services sector, has surpassed the target for its third fund and is keeping the fund open, a source familiar with the fundraising told […]
Baltimore's ABS marching toward $400M target
Firm: Catterton Partners Fund: Catterton Partners VII LP Target: $1.25-$1.5 billion Placement Agent: None Catterton Partners, a specialist in food, retail, media and consumer products, plans to raise its seventh fund early next year, a source familiar with the firm’s plans told Buyouts. The target is expected to range from $1.25 billion to $1.5 billion. […]
Pennsylvania-based buyout shop likely to hold final close near $240M in fall
3M has agreed to sell its global pharmaceuticals division in three separate deals worth a total of around $2.1 billion. First, Graceway Pharmaceuticals, a Bristol, Tenn.-based drug company owned by GTCR, will pay $875 million for 3M’s pharma operations in the U.S., Canada and Latin America. Graceway also will subsume fellow GTCR portfolio company Chester […]

Copyright PEI Media

Not for publication, email or dissemination